These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16044500)

  • 1. The roles of BRCA1 and BRCA2 in the cellular response to ionizing radiation.
    Powell SN
    Radiat Res; 2005 Jun; 163(6):699-700. PubMed ID: 16044500
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlight: BRCA1 and BRCA2 proteins in breast cancer.
    Daniel DC
    Microsc Res Tech; 2002 Oct; 59(1):68-83. PubMed ID: 12242698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.
    Rashid MU; Torres D; Zaidi A; Rasheed F; Sultan F; Shakoori AR; Amin A; Hamann U
    Breast Cancer Res Treat; 2008 Jan; 107(1):155-6. PubMed ID: 18043900
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.
    Walker LC; Thompson BA; Waddell N; ; Grimmond SM; Spurdle AB
    PLoS Genet; 2010 Feb; 6(2):e1000850. PubMed ID: 20174566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 promotes induction of ssDNA by ionizing radiation.
    Schlegel BP; Jodelka FM; Nunez R
    Cancer Res; 2006 May; 66(10):5181-9. PubMed ID: 16707442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
    Zhang J; Powell SN
    Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures.
    Hedenfalk IA
    J Natl Cancer Inst; 2002 Jul; 94(13):960-1. PubMed ID: 12096075
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.
    Hedau S; Batra M; Singh UR; Bharti AC; Ray A; Das BC
    J Cancer Res Ther; 2015; 11(1):158-63. PubMed ID: 25879355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCoR-L1 variation and breast cancer.
    Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
    Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA-related ovarian carcinoma.
    Rubin SC
    Cancer; 2003 May; 97(9):2127-9. PubMed ID: 12712461
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer.
    Ziogas D; Liakakos T; Lykoudis E; Fatourou E; Roukos DH
    Radiother Oncol; 2009 Jan; 90(1):161-2. PubMed ID: 18343512
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.
    Tutt A; Ashworth A
    Trends Mol Med; 2002 Dec; 8(12):571-6. PubMed ID: 12470990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells.
    Glait C; Ravid D; Lee SW; Liscovitch M; Werner H
    FEBS Lett; 2006 Oct; 580(22):5268-74. PubMed ID: 16979166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
    Golshan M; Miron A; Nixon AJ; Garber JE; Cash EP; Iglehart JD; Harris JR; Wong JS
    Am J Surg; 2006 Jul; 192(1):58-62. PubMed ID: 16769276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.